Report
drawn up on behalf of the Committee on the Environment, Public Health and
Consumer Protection
on the proposals from the Commission of the European Communities to the
Council (Doc. 132/76) for
I. a directive on the approximation of the laws of Member States relating to
veterinary medicinal products
II. a directive on the approximation of the laws of Member States relating to analytical, pharmacotoxicological and clinical standards and protocols in
respect of the testing of veterinary medicinal products. EP Working Documents, document 421/76, 15 November 1976 by Ney, C.
1 S November 1976 
English Edition 
European Communities LIBRARl 
EUROPEAN PARLIAMENT 
Working Documents 
1976 - 1977 
DOCUMENT 421/76 
Report 
drawn up on behalf of the Committee on the Environment. Public Health and 
Consumer Protection 
on the proposals from the Commission of the European Communities to the 
Council (Doc. 132/76) roy 
I. a directive on the approximation of the laws of Member States relating to 
veterinary medicinal products 
II. a directive on the approximation of the laws of Member States relating to . 
analytical, pharmacotoxicological and clinical standards and protocols in 
respect of the testing of veterinary medicinal products 
Rapporteur: Mr C. NEY 
I• 
PE 46.008/fin. 

r By lett~r of 26 May 1976 the President of the council of the European 
Communities requested the European Parliament to deliver an opinion on the 
proposalsfrom the Commission of the European Communities for directives 
on the approximation of the laws of Member States relating to veterinary 
medicinal products and the approximation of the laws of Member States 
relating to analytical, pharmaco-toxicological and clinical standards and 
protocols in respect of the testing of veterinary medicinal products. 
The President of the European Parliament referred these proposals 
to the Committee on the Environment, Public Health and Consumer Protection 
as the committee responsible and to the Committee on Economic and Monetary 
Affairs for its opinion. 
on 23 June 1976 the committee on the Environment, Public Health and 
consumer Protection appointed Mr Ney rapporteur. 
It·considered these proposals at its meetings of 23 June, 28.September 
and 28 October 1976 and unanimously adopted the motion for a resolution 
and explanatory statement at the last meeting. 
Present: Mr Jahn, acting chairman and vice-chairman; Mr Ney, 
rapporteur; Mr Ajello, Mr Didier, Mr Glinne (deputizing for Mr Walkhoff), 
Mr Guerlin, Sir Peter Kirk, Mr Martens, Mr Noe (deputizing for Mr H!rzschel), 
Mr Radoux (deputizing for Mr Adams), Mr Schwabe, Mrs Squarcialupi and 
Mr Veronesi. 
The opinion of the Committee on gconomic and Monetary Affairs is 
attached. 
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J 
A 
The Committee on the Environment, Public llcalth and consun,c.~i· Protol'l.ion 
hereby submits to the European Parliament the following motion for a resolution, 
together with explanatory statement: 
MOTION FOR A RESOLUTION 
embodying the opinion of the European Parliament on the proposals from the 
Commission of the European Communities to the council 
I. a directive on the approximation of the laws of Member States relating to 
veterinary medicinal products 
II. a directive on the approximation of the laws of Member States relating to 
analytical, pharmaco-toxicological and clinical standards and protocols 
in respect of the testing of veterinary medicinal products 
The European Parliament, 
- having regard to the proposal from the commission of the European Communities 
to the Councill 
- having been consulted by the Council pursuant to Article 100 of the EEC 
Treaty (Doc. 132/76) 
- having regard to the report of the Committee on the Environment, Public 
Health and consumer Protection and the opinion of the Committee on Economic 
and Monetary Affairs (Doc. 421/76), 
1. Notes with satisfaction that, with the present proposals for directives, 
the Commission has taken a first step towards achieving the free movement 
of veterinary medicinal products: 
2. Welcomes the Commission's endorsement of the principle that any regulations 
in the field of the production and distribution of these medicinal products 
must have the safeguarding of publie health as its main objective: 
3. Regrets, however, that the Commission has opted for the introduction in 
stages of propo~als which are too limited both in scope and content: 
4. Considers that the envisaged reciprocal recognition of authorisations to 
place veterinary medicinal products on the market should have been treated 
within the framework of this directive: 
l OJ No. C 152, 5.7.1976, p.l 
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5. Recommends the Commission, in view of the increasingly industrial nature 
of stock-breeding and in view of the fact that the number of veterinary 
preparations is distinctly smaller than the number used in human medicine, 
to broaden the field of application of the present proposals to cover 
medicated feedingstuffs, serums and vaccines: 
6. Also regrets that, in the interests of the ultimate user, the distribution 
of and publicity for these medicinal products is not satisfactorily 
regulated: 
7. Considers it desirable that supervision and inspection of the authori-
sations granted by the Member States should continue to be carried out in 
the first instance by the competent authorities of the Member States 
concerned; 
B. Considers that it is not desirable to set up a new committee for veterinL 
ary medicinal products, since the tasks it is intended to assume can be 
taken over by one of the existing committees; 
9. Requests the commission to incorporate the following amendments in its 
proposal, pursuant to article 149, second paragraph, of the EEC Treaty. 
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ll·XI' l'IWl'OSH> HY I HI· ( OMMISSION OF 
I Ill: HIIWl'b\N COMMUNl'I IES 
,\Ml:Nlll:ll ll- X I 
l'ropoRa.l.s fol" Counei 1 r>I nwLivett: 
I. on the approximation of the laws of Member States 
relating to veterinary medicinal products 
II. on the approximation of the laws of Member States relating 
to analytical, pharmacotoxicological and clinical standards 
and protocols in respect of the testing of veterinary 
-medicinal products 
(Submitted to the .council by the Commission on 13 May 1976) 
I 
Proposal for a council Directive on the approximation of the 
laws of Member States relating to veterinary medicinal products 
THE COUNCIL OF THE EUROPEAN COMMUNITIES, 
Having regard to the Treaty estab-
lishing the European Economic 
Community, and in particular 
Article 100 thereof, 
Having regard to the proposal from 
the Commission, 
Having regard to the opinion of the 
European Parliament, 
Having regard to the opinion of the 
Economic and Social Committee, 
Whereas the primary purpose of any 
rules for the production and 
distribution of veterinary medicinal 
products must be the safaguarding 
of public health; 
Whereas, however, this objective 
must be achieved by means which will 
not hinder the development of 
industry and trade in medicinal 
products within the Community; 
Whereas, in so far as the Member States 
already have certain provisions laid 
down by law, regulation or 
administrative action governing 
veterinary medicinal products, such 
provisions differ in essential 
principles; whereas this results 
in the hindering of trade in 
medicinal products within the Community 
and thereby directly affects the 
establishment and functioning of the 
common market; 
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unchanged 
unchanged 
unchanged 
unchanged 
unchanged 
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TEXT PROPOSE!) BY THE COMMISSION OF 
THE EUROPEAN COMMUNITIES 
Whereas such hindrances must 
accordingly be removed; whereas this 
entails approximation of the 
relevant provisions; 
Whereas the provisions of this 
Directive which concern veterinary 
medicinal products are not 
adequate, although appropriate, 
for veterinary medicinal product• 
unad to con fer act l ve immunity, to 
diaqnoso the state of immunity 
and to confer passive immunity 
and for medicinal products based 
on radioactive isotopes; whereas it 
is therefore advisable not to 
prescribe their application to such 
products for the present; 
Whereas medicated feedingstuffs do 
not come within the ambit of this 
Directive; whereas it is necessary, 
as much for public health as economic 
reasons, to prohibit the use of 
unauthorized medicinal products in 
the manufacture of medicated 
feedingstuffs; 
Whereas marketing authorization shall 
be refused where a medicinal product 
lacks therapeutic effect or where 
there is insufficient proof of such 
effect promised by the 
manufacturers; 
Whereas it is advisable, in order 
gradually to achieve freedom of 
movement of veterinary medicinal 
products, to facilitate the 
granting of marketing 
authorization in several Member 
States for one and the same medicinal 
product; 
Whereas, for this purpose, a 
Committee for Veterinary Medicinal 
Products should be set up, composed 
of representatives of the Member 
States and of the Commission, 
responsible for giving an opinion 
as to whether a particular 
veterinary medicinal product 
complies with the requirements set 
out in this Directive; 
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AMENDED TEXT 
unchanged 
Whereas the provisions of this 
Directive which concern 
veterinary medicinal products 
are not adequate, although 
appropriate, for veterinary 
medicinal products based on 
radioactive isoptopea; whereas 
it is therefore advisable not 
to prescribe their application 
to such products for the present; 
deleted 
unchanged 
Whereas it is advisable, in order 
gradually to achieve freedom of 
movement of veterinary medicinal 
products, to facilitate the 
granting of marketing authoriz-
ations in the Member States for 
one and the same medicinal product; 
Whereas, for this purpose, the 
Pharmaceutical Committee composed 
of representatives of the Member 
States and of the Commission, 
should be able to give an opinion 
as to whether a particular 
veterinary medicinal product 
complies with the requirements set 
out in this Directive; 
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TEXT PROPOSl:D BY THE COMMISSION OF 
THE EUROPEAN COMMUNITIES 
Whereas this Directive is only 
one stage in the achievement of 
the aim of freedom of movement of 
veterinary medicinal products; 
whereas, for this purpose, new 
measures will prove necessary, in 
the light of experience gained, 
especially within the said 
Committee, for the removal of the 
remaining barriers to freedom of 
movement; 
Whereas, in order to facilitate 
the movement of veterinary medicinal 
products and to prevent the checks 
carried out in one Member State 
from being repeated in another, 
minimum requirements for 
manufacture and imports from third 
countries and the grant of 
authorization relating thereto, 
should be applied to veterinary 
medicinal products, as specified in 
second Council Directive 75/319/EEC 
of 20 May 1975 on the approximation 
of provisions laid down by law, 
regulation or administrative action 
relating to proprietary medicinal 
products, 
HAS ADOPTED THIS DIRECTIVE: 
CHAPTER I 
Definitions and scope of application 
AMENDED TEXT 
Whereas, to achieve freedom of 
movement of veterinary medicinal 
products, further measures will 
prove necessary in the light 
of experience gained, especially 
within the said committee; 
unchanged 
HAS ADOPTED THIS DIRECTIVE: 
CHAPTER I 
Definitions and scope of application 
Articlo l 
unchanged 
Article 2 
l. The provisions of this Directive 
shall apply to veterinary medicinal 
products whether offered for sale in 
the form of proprietary medicinal 
products, ready-made veterinary 
medicinal products or premixes. 
2. The provisions of this Directive 
shall not apply to: 
(a) medicated feedingstuffs; 
(b) veterinary medicinal products 
used with a view to producing 
active immunity, diagnosing 
the state of immunity and 
producing passive immunity; 
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Article 2 
l. The provisions of this Directive 
shall apply to veterinary medicinal 
products whether offered for sale in 
the form of proprietary medicinal 
products, ready-made veterinary 
medicinal products, premixes, or 
medicated feedingstuffs. 
2. The provisions of this Directive 
shall not apply to: 
(a) veterinary medicinal products 
based on radioactive isotopes; 
(b) veterinary medicinal products not 
prepared in advance and intended 
for one animal. 
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TEXT PIWPOSl· 11 UY 1111: ( OMMISSION 01' 
riff HIIWPb\N ('OMMllNI IIES 
(1•) v(,t,,ri11o1ry m111li,•l1i.-1I pr(lrl11cb1 
lii'IHnd 011 1·,Hlio,ll·l lv1• iflolop,•n; 
(d) veterinary medicinal products 
not prepared in advance and 
intended for one particular 
animal. 
AMENDED ·11:x1 
3. However, pending separate provisions 3. unchanged 
for medicated feedingstuffs, a pre-
mix shall not be used for the 
manufacture of medicated feedingstuffs 
if it has not received the author-
ization referred to in Article 3. 
Articles 3 to 13 unchanged 
Article 14 
/\111 llor l:t.nl 11111 1:11inl I l,tt vnl td for 
rl Vi:> y~n r ~ nnrl 1:111,, I I It., I rlll~Wl'liil f:I 
for five-year perlrnln, 011 
application by the holder with.l.n 
the three months preceding the date of 
expiry, in accordance with the 
provisions of Article 13. 
Article 15 
1. In order to facilitate the 
adoption of a common position by the 
Member States with regard to 
marketing authorizations, a Committee 
for Veterinary Medicinal Products, 
hereinafter called 'the conunittee', 
is hereby set up: it shall be composed 
of representatives of the Member States 
and of the Conunission. 
2. The Committee shall, when so requested 
by a Member State, examine questions 
relating to the implementation of 
Articles 10, 20 and 33, in accordance 
with Articles 16 to 21. 
3. The Conunittee shall draw up its own 
rules of procedure. 
Article 14 
Author l zrtl 1011 1,1h11 I I Im vnJ id for 
11 Vtl yt1n1 N rtllrl nl1rll I l,n l"f111<lWl'lld n 
lot I iv,,. ynnt pnrlod», 011 nppl l,·nl Ion 
by tlto ltoldor al loasl throe mo11Lhn 
before the date of expiry, in 
accordance with the provisions of 
Article 13. 
Article 15 
In order to facilitate the adoption 
of a common position by the Member 
States with regard to marketing 
authorizations, the pharmaceutical 
Conunittee, composed of representatives 
of the Member States and of the 
Conunission shall, when so requested 
by a Member State, examine questions 
relating to the implementation of 
.Articles 10, 20 and 33, in accordance 
with Articles 16 to 21. 
Article 19 
Articles 16 to 18 unchanged 
Article 19 
1. If several applications have been 1. unchanged 
submitted in accordance with Article 4 
for marketing authorization 
for the same veterinary medicinal 
product, and oreor moro Member States 
have granted such authorization while 
one or more of the other Member 
States have refused it, one of the 
Member states concerned may bring 
the matter before the conunittee. 
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TEXT PROP0St::D BY THI: COMMISSION OF 
THE EUROPEAN COMMUNITIES 
The same shall apply where one or more 
Member States have suspended or withdrawn 
marketing authorization while one or 
more of the other Member States have 
not done so. 
2. The Committee shall consider ..• 
3. The opinion of the Committee ••. 
4. The Member States concerned •.. 
AMENl}El) TEXT 
If one or more Member States have 
suspended or withdrawn marketing 
authorization the Committee shall 
be informed of this decision 
forthwith. 
2. unchanged 
3. unchanged 
4. unchanged 
Articles 20 to 32 unchanged 
Article 33 
The following particulars •.• 
Subsections 
7. delay if any; 
Subsections 
The pharmaceutical form .•. 
The provisions of Part l(a) 
1 to 
8 to 
Article 
unchanged 
6 unchanged 
7. if necessaryi 
11 unchanged 
unchanged 
unchanged 
33 
the delayi 
Article 43 
Articles 34 to 42 unchanged 
Article 43 
1. As regards the authorization ...•. 
2. The other provisions of this 
Directive shall be applied progres-
sively, within 15 years of the 
notification referred to in Article 42, 
to veterinary medicinal products placed 
on the market by virtue of 
previous provisions. 
3. Member States shall notify the 
Commission, within three years fol-
lowing the notification of this 
Directive, of the number of 
veterinary medicinal products 
covered by paragraph 2, and, 
in each subsequent year, of the 
number of such products for which 
the marketing authorization 
referred to in Article 3 has not 
yet been issued. 
1. unchanged 
2. The other provisions of this 
Directive shall be applied 
progressively, within five years 
of __ i ts ent;:y into force, to 
veterinary medicinal proQucts 
placed on the market by virtue 
of previous provisions. 
3. unchanged 
Article 44 unchanged 
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TEXT PROPOSED HY THE COMMISSION OF 
THE EUROPEAN COMMUNITIES 
II 
Al\1ENl>ED TEXT 
Proposal for a Council Directive on the approximation of the 
laws of Member States relating to analytical, pharmaco-
toxicological and clinical standards and protocols in respect 
of the testing of veterinary medicinal products 
Preamble and recitals unchanged 
Article 1 unchanged 
Article 2 
The amendments necessary for 
adapting the requirements of the 
Annex to this Directive to technical 
progress shall be adopted in 
accordance with the procedure 
laid down in Article 3(5) and (6) 
(as amended) of the Council Directive 
of ••• relating to analytical, pharmaco-
toxicological and clinical standards 
and protocols in respect of the 
testing of proprietary medicinal 
products. 
The Commi ttoo ro for.r. o<l to in 
Article 3 (as amended) of the said 
Directive may examine any question 
relating to the application of this 
Directive which is brought up by its 
chairman, either on his own 
initiative or at the request of the 
representative of a Member State. 
Article 2 
The amendments necessary for 
adapting the requirements of the 
Annex to this Directive to 
technical progress shall be 
adopted in accordance with the 
procedure laid down in Article 
3(5) and (6) (as amended) of the 
Council Directi. ve of 20 May 1975 
(75/318/EEC) relating to analytical, 
pharmaco-toxicological and 
clinical standards and protocols 
in respect of the testing of 
proprietary medicinal products. 
'!'he Pharmaceutical Committee 
set up by the Council Decision 
of 20 May 1975 (75/320/EEC) may 
examine any question relating to 
the application of this Directive 
which is brought up by its 
chairman, either on his own 
initiative or at the request of the 
representative of a Member State. 
Articles 3 and 4 unchanged 
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B 
EXPIANATORY STATEMENT 
I. PROPOSAL FOR A COUNCIL DIRECTIVE ON THE APPROXIMATION OF THE LAWS OF MEMBER 
STATES REIATING TO VETERINARY MEDICINAL PRODUCTS 
A. GENERAL OBSERVATIONS 
1. The present proposal for a Council directive is a first step towards 
approximating the laws of Member States relating to the marketing of 
veterinary medicinal products. 
2. The aim is to apply uniform standards in granting authorizations for 
the production and distribution of these medicinal products. To achieve 
this, the Commission has opted to introduce proposals designed to implement 
for a number of such products the system which is already applicable to 
those used in human medicine. It considers that in this way the free move-
ment of the medicinal products in question will be attained more rapidly 
than by means of proposals which are too broadly conceived. 
3. It should be pointed out that the removal of existing barriers and the 
elimination of unfair competition for the production, distribution and 
administering of veterinary medicinal products must be accompanied by the 
most effective possible safeguards for public health. Your committee 
welcomes the endorsement of this principle as a sine qua non. The standards 
applied in connection with the administration of medicinal products to 
animals must not be allowed to fall below those applied to products used in 
human medicine. It notes with satisfaction, therefore, the standards laid 
down in Article 4, which must be complied with before authorization is 
granted. 
4. However, it should be noted that the scope and content of this proposal 
for a directive are somewhat limited. The aim is that the Member States 
should employ the same standards, data and documents when granting authoriza-
tions for the marketing of veterinary medicinal products. Your committee 
regards this measure as a fundamental matter which must be settled in advance, 
but points out that the authorizations for marketing medicinal products 
remain valid only in the Member State where they were delivered. Moreover, 
it considered it highly desirable that the provisions of this directive 
should also be applicable to premixes, medicated feedingstuffs, serums and 
vaccines. In particular the administering of medicated feedingstuffs and the 
suppression of the current black market in this area calls for early 
Community legislation. 
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5. Your committee would also have liked to see the Commission go a stage 
further towards reciprocal recognition of authorizations granted in the 
different Member States. In fact it is left to the producer or to whoever 
is responsible for marketing the product to limit the use of these 
products to one or more Member States. Through common expert research 
and the submission of a number of uniform data and documents as laid down 
in Article 4, the committee belives it should be possible in the near future 
to achieve the free movement of existing and new and better-quality 
veterinary medicinal products. This cannot but contribute to the protection 
of public health. 
6. This proposal is thus too modest and fragmentary in its approach to 
the problem of reciprocal recognition of authorizations for marketing 
veterinary medicinal producta either about to be or already granted. ·rhe 
proposed amendmentA, therefore, aim at extnnding tho field of application 
of the proposal for a directive and at shortening the transitional period 
leading up to the free movement of veterinary medicinal products. Your 
committee hopes that the Commission will soon draw up more extensive pro-
posals in this field to include a procedure for granting a European 
authorization. 
B. PROPOSED AMENDMENTS 
7. Fifth recital and Article 2 
---------------------------
As already stated in point 4, the Committee on the Environment, Public 
Health and consumer Protection considers that this proposal for a directive 
should also be applicable - given the large quantities involved - to pre-
mizes, serums, vaccines and in particular to medicated feedingstuffs which 
are not ,dmod so mud1 nt improvin9 tho q11;1 Ii ty of ,rnimal products hut rather 
at an accelerated and greater increase in growth, and which, if not strin-
gently supervised, could easily be abused. 
8. Sixth recital 
This naturally goes out with the adoption of the preceding amendment. 
9. Ei~hth_recital 
The committee wishes to emphasize that the purpose here is to give 
prominence to the ultimate objective of free movement with regard to the 
marketing of veterinary medicinal products. Replacing the words ' •.. in 
several Member States' by' ••• in the Member States' makes this objective 
clearer. 
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10. Ninth recital and Article 15 
The Committee on the Environment, Public Health and Consumer Protection 
considers superfluous the setting up of a new 'Committee for Veterinary 
Medicinal Products'. There are already in existence a Standing Veterinary 
Committee, a Standing Committee for Animal Feedingstuffs, a Pharmaceutical 
Committee and a Committee for Proprietary Medicinal Products. In view of the 
limited number of veterinary medicinal products and the need to safeguard 
public health, it is proposed that the problems raised in Articles 16 to 21 
should be dealt with by the Pharmaceutical Committee. The Commission has 
also pronounced favourably on this. 
11. Article 14 
In theory, the holder of an authorization would be able to apply for a 
five-year renewal on the last day before the date of expiry. To prevent any 
possible misunderstandings and to allow sufficient time for the competent 
national authorities to examine applications, the proposal aims to make the 
wording more precise. 
l:l.. Article 43 
IJnAinq iUwlf on lho 1.1!-month period laid down In /\rlic:l<' 4?. for lh<' 
implementation of thiA directive, the Committee on the gnvironment, Public 
Health and Consumer Protection considers that the proposed 15-year period 
for applying the provisions of this directive to veterinary medicinal products 
that have been marketed in accordance with previous provisions should be 
reduced to five years. Otherwise, the free movement of the products in 
question would be delayed too long by this transitional directive. 
IL~ROPOSAL FOR A Ca.JNCIL DIRECTIVE ON THE APPROXIMATION OF THE LAWS OF MEMBER 
STATES RELATING TO ANALYTICAL, PHARMACO-TOXICOLOGICAL AND CLINICAL STANDARDS 
AND PROTOCOLS IN RESPECT OF THE TESTING OF VETERINARY MEDICINAL PROWCT'S 
The committee on the Environment, Public Health and Consumer Protection 
approves this proposal. The proposed amendments simply complete the pro-
poAed text with the Council Directive of 20 May 1975 (7S/318/EEC) already 
approved and by men~ing the Pharmaceutical Committee, which was also set 
up on 20 May 1975 (75/320/EEC). 
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OPINION OF THE COMMITTEE ON ECONOMIC AND MONETARY AFFAIRS 
Letter from the chairman of the committee to the chairman of the committee 
on the Environment, Public Health and Consumer Protection 
27 September 1976 
At its meeting of 23 and 24 September 1976 the Committee on Economic 
and Monetary Affairs discussed the proposals from the Commission of the 
European Communities to the Council for a directive on the approximation 
of the laws of Member States relating to veterinary medicinal products and 
a directive on the approximation of the laws of Member States relating to 
analytical, pharmaco-toxicological and cliaical standards and protocols jn 
respect of the testing of veterinary medicinal products (Doc. 132/76). 
The first proposal in particular could considerably influence free 
trade in these products. Although complete freedom of movement would in 
principle be possible, the Co~ission prefers to introduce it by stages. 
The Commission's proposal can therefore be regarded as merely a first step 
towards making free trade in these products a reality. 
The Commission proposes introducing, in the case of veterinary medicinal 
products, the system already existing for medicinal products for human use. 
The committee obviously agrees that for reasons of public health, 
authorization should be obtained for the marketing of veterinary medicinal 
products, since any medicinal residues in animals used for human consumption 
have a direct effecl on human health. The Commission proposes national 
authorizalion, which means that producers of veterinary medidnal products 
must lodge applications in each Member State in which they wish to market 
them: this must be regarded as an administrative obstacle to free trade. 
The Committee on Economic and Monetary Affairs therefore earnestly urges 
the Commission to introduce a system in which marketing authorization would 
cover the whole Community in the new proposal it is to submit to the council 
not later than four years after the entry into force of the directive, 
pursuant to Article 22(2) of the proposal for a directive. 
Please treat this letter as the opinion for your committee on the 
above Commission proposals (Doc. 132/76). The opinion was unanimously 
1 
adopted . 
1 
Yours sincerely, 
on behalf of the committee, 
( sgd . ) K. NYBORG 
Draftsman of the opinion 
Present: Mr van der HEK (chairman), Lord ARDWICK, Mr ARTZINGER, 
Mr FABBRINI, Lord GORDON WALKER, Mr HOUGARDY, Mr NORMANTON, Mr SPRING ORUM 
(deputizing for Mr SCHWORER), Mr SUCK and Mr THORNLEY 
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